echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Diabetes Care: Don't just care about glycation, but also pay attention to these when using insulin therapy for type 2 diabetes!

    Diabetes Care: Don't just care about glycation, but also pay attention to these when using insulin therapy for type 2 diabetes!

    • Last Update: 2021-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Glycated hemoglobin (HbA1c) is a clinically recognized standard for monitoring blood glucose control.
    It is linearly related to the average blood glucose concentration in the past 2-3 months.
    It is a useful tool for monitoring long-term blood glucose control in diabetic patients
    .


    Prevention of micro associated with chronic hyperglycemia vascular complications, is a major therapeutic goal


    Glycated hemoglobin (HbA1c) is a clinically recognized standard for monitoring blood glucose control.


    In type 1 and type 2 diabetes, there is a clear relationship between HbA1c and the risk of microvascular complications


    However, the use of HbA1c has important limitations


    To study the glucose changes associated with HbA1c in insulin-treated type 2 diabetes (T2D) patients, the results of the study were published in the journal Diabetes Care
    .


    The researchers enrolled in DIALECT-2 patients (n = 79) were divided into three HbA1c categories: low, medium, and high (respectively ≤53, 54-62 and ≥63mmol/mol or ≤7, 7.


    The results showed that the median (IQR) of CGM was 10 (7-12) days/patient
    .


    There was no difference in TIR between the low-level and intermediate HbA1c categories (76.


    There was no difference in TIR between the low-level and intermediate HbA1c categories (76.


    The median values ​​of TIR, TBR1, TBR2, TAR1 and TAR2 are divided into HbA1c≤53 mmol/mol, HbA1c 54-62 mmol/mol and HbA1c≥63 mmol/mol
    .

    Patients in the highest HbA1c category had lower TIR (52.
    7% [40.
    9-67.
    3]) and higher TAR (44.
    1% [27.
    8-57.
    0]) than patients in other HbA1c categories, but there was no reduction in TBR at night
    .


    All patients had more (0.


    Patients in the highest HbA1c category had lower TIR (52.


    In this study, high HbA1c did not reduce the occurrence of nighttime hypoglycemia, and low HbA1c was not associated with the highest TIR


     

    references:

    Glucose Regulation Beyond HbA1c in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.